May MIMS update

We look at some of the recent changes to the medicines landscape, with new products as well as changes to indications New Products LetibotulinumtoxinA (Letybo) blocks cholinergic transmission at the neuromuscular junction by inhibiting the release of acetylcholine from peripheral cholinergic nerve terminals. This inhibition occurs according to the following sequence: heavy chain of toxin